Overview

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Status:
Completed
Trial end date:
2008-09-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. OGX-011 may help docetaxel kill more tumor cells by making tumor cells more sensitive to the drug. PURPOSE: This phase II trial is studying how well giving OGX-011 together with docetaxel works in treating women with locally advanced or metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
NCIC Clinical Trials Group
Treatments:
Docetaxel